A formulation comprising botulinum toxin (BT), lipid and surfactant, characterised in that the lipid and surfactant are in the form of macromolecular assemblies of less than 100 nm in diameter. The surfactant may have an HLB number of less than 20. Cosmetic and pharmaceutical formulations and corresponding uses are contemplated and included, as are methods of preparation,